Trademark: 88401758
Status Date
Thursday, March 18, 2021
Filing Date
Thursday, April 25, 2019
Abandoned Date
Friday, February 26, 2021
5 Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
Mar 18, 2021
Abandonment Notice E-Mailed - Failure To Respond
Mar 18, 2021
Abandonment - Failure To Respond Or Late Response
Aug 25, 2020
Notification Of Non-Final Action E-Mailed
Aug 25, 2020
Non-Final Action E-Mailed
Aug 25, 2020
Non-Final Action Written
Aug 25, 2020
Lie Checked Susp - To Atty For Action
Aug 21, 2020
Assigned To Lie
Jan 24, 2020
Notification Of Letter Of Suspension E-Mailed
Jan 24, 2020
Letter Of Suspension E-Mailed
Jan 24, 2020
Suspension Letter Written
Jan 16, 2020
Teas/Email Correspondence Entered
Jan 15, 2020
Correspondence Received In Law Office
Jan 15, 2020
Teas Response To Office Action Received
Jul 16, 2019
Notification Of Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action E-Mailed
Jul 16, 2019
Non-Final Action Written
Jul 8, 2019
Assigned To Examiner
May 10, 2019
New Application Office Supplied Data Entered In Tram
Apr 29, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
